Global quantitative proteomic analysis of human glioma cells profiled host protein expression in response to enterovirus type 71 infection

Proteomics

Volumn 15, Issue 22, 2015, Pages 3784-3796

  Zhang, Lei Ke ^a   Lin, Tao ^b   Zhu, Sheng Lin ^a   Xianyu, Ling Zhi ^b   Lu, Song Ya ^b  

^a WUHAN INSTITUTE OF VIROLOGY   (China)

^b WUHAN UNIVERSITY   (China)

Author keywords

Cell biology; EV71; Quantitative proteomics; SILAC; TRAF2; TRAF6

Indexed keywords

BETA INTERFERON; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; PROTEOME;

ARTICLE; BIOINFORMATICS; ENTEROVIRUS 71; ENTEROVIRUS INFECTION; GENE ONTOLOGY; GLIOMA CELL; HUMAN; HUMAN CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEOMICS; QUANTITATIVE ANALYSIS; UPREGULATION; VIRUS REPLICATION; WESTERN BLOTTING; BIOLOGY; ENTEROVIRUS A; GLIOMA; HAND FOOT AND MOUTH DISEASE; HOST PATHOGEN INTERACTION; PHYSIOLOGY; TUMOR CELL LINE; VIROLOGY;

CELL LINE, TUMOR; COMPUTATIONAL BIOLOGY; ENTEROVIRUS A, HUMAN; GLIOMA; HAND, FOOT AND MOUTH DISEASE; HOST-PATHOGEN INTERACTIONS; HUMANS; PROTEOME; TNF RECEPTOR-ASSOCIATED FACTOR 2; TNF RECEPTOR-ASSOCIATED FACTOR 6; VIRUS REPLICATION;

EID: 84954373784     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201500134     Document Type: Article

References (54)

1. Solomon, T., Lewthwaite, P., Perera, D., Cardosa, M. J. et al., Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect. Dis. 2010, 10, 778-790.
2. Frydenberg, A., Starr, M., Hand, foot and mouth disease. Aust. Fam. Physician 2003, 32, 594-595.
3. Chan, L. G., Parashar, U. D., Lye, M. S., Ong, F. G. et al., Deaths of children during an outbreak of hand, foot, and mouth disease in sarawak, malaysia: clinical and pathological characteristics of the disease. For the Outbreak Study Group. Clin. Infect. Dis. 2000, 31, 678-683.
4. Zhang, D., Lu, J., Enterovirus 71 vaccine: close but still far. Int. J. Infect. Dis. 2010, 14, e739-e743.
5. Li, Y. P., Liang, Z. L., Gao, Q., Huang, L. R. et al., Safety and immunogenicity of a novel human Enterovirus 71 (EV71) vaccine: a randomized, placebo-controlled, double-blind, Phase I clinical trial. Vaccine 2012, 30, 3295-3303.
6. Kim, Y., Lovell, S., Tiew, K. C., Mandadapu, S. R. et al., Broad-spectrum antivirals against 3C or 3C-like proteases of picornaviruses, noroviruses, and coronaviruses. J. Virol. 2012, 86, 11754-11762.
7. Wong, K. T., Munisamy, B., Ong, K. C., Kojima, H. et al., The distribution of inflammation and virus in human enterovirus 71 encephalomyelitis suggests possible viral spread by neural pathways. J. Neuropathol. Exp. Neurol. 2008, 67, 162-169.
8. Zhang, Y., Cui, W., Liu, L., Wang, J. et al., Pathogenesis study of enterovirus 71 infection in rhesus monkeys. Lab. Invest. 2011, 91, 1337-1350.
9. Ooi, M. H., Wong, S. C., Lewthwaite, P., Cardosa, M. J., Solomon, T., Clinical features, diagnosis, and management of enterovirus 71. Lancet Neurol. 2010, 9, 1097-1105.
10. Xu, J., Qian, Y., Wang, S., Serrano, J. M. et al., EV71: an emerging infectious disease vaccine target in the Far East? Vaccine 2010, 28, 3516-3521.
11. Hao, B., Gao, D., Tang, D. W., Wang, X. G. et al., [Distribution of human enterovirus 71 in brainstem of infants with brain stem encephalitis and infection mechanism]. Fa Yi Xue Za Zhi 2012, 28, 85-88, 91.
12. Peng, T., Strategies for antiviral screening targeting early steps of virus infection. Virol. Sin. 2010, 25, 281-293.
13. Kilcher, S., Mercer, J., Next generation approaches to study virus entry and infection. Curr. Opin. Virol. 2014, 4, 8-14.
14. Shih, S. R., Stollar, V., Lin, J. Y., Chang, S. C. et al., Identification of genes involved in the host response to enterovirus 71 infection. J. Neurovirol. 2004, 10, 293-304.
15. Lui, Y. L., Tan, T. L., Timms, P., Hafner, L. M. et al., Elucidating the host-pathogen interaction between human colorectal cells and invading Enterovirus 71 using transcriptomics profiling. FEBS Open Bio. 2014, 4, 426-431.
16. Xu, L. J., Jiang, T., Zhang, F. J., Han, J. F. et al., Global transcriptomic analysis of human neuroblastoma cells in response to enterovirus type 71 infection. PLoS One 2013, 8, e65948.
17. Nie, L., Wu, G., Culley, D. E., Scholten, J. C., Zhang, W., Integrative analysis of transcriptomic and proteomic data: challenges, solutions and applications. Crit. Rev. Biotechnol. 2007, 27, 63-75.
18. Leong, W. F., Chow, V. T., Transcriptomic and proteomic analyses of rhabdomyosarcoma cells reveal differential cellular gene expression in response to enterovirus 71 infection. Cell Microbiol. 2006, 8, 565-580.
19. Lee, J. J., Seah, J. B., Chow, V. T., Poh, C. L., Tan, E. L., Comparative proteome analyses of host protein expression in response to Enterovirus 71 and Coxsackievirus A16 infections. J. Proteomics 2011, 74, 2018-2024.
20. Zhang, L. K., Chai, F., Li, H. Y., Xiao, G., Guo, L., Identification of host proteins involved in Japanese encephalitis virus infection by quantitative proteomics analysis. J. Proteome Res. 2013, 12, 2666-2678.
21. Chai, F., Li, H. Y., Wang, W., Zhu, X. J. et al., Subcellular quantitative proteomic analysis reveals host proteins involved in human cytomegalovirus infection. Biochim. Biophys. Acta 2015, 1854, 967-978.
22. Vizcaino, J. A., Cote, R. G., Csordas, A., Dianes, J. A. et al., The PRoteomics IDEntifications (PRIDE) database and associated tools: status in 2013. Nucleic Acids Res. 2013, 41, D1063-D1069.
23. Mi, H., Muruganujan, A., Thomas, P. D., PANTHER in 2013: modeling the evolution of gene function, and other gene attributes, in the context of phylogenetic trees. Nucleic Acids Res. 2012, 41, D377-D386.
24. Emmott, E., Goodfellow, I., Identification of protein interaction partners in mammalian cells using SILAC-immunoprecipitation quantitative proteomics. J. Vis. Exp. 2014, 89, e51656.
25. Ishikawa, H., Barber, G. N., STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 2008, 455, 674-678.
26. Takeuchi, O., Akira, S., Innate immunity to virus infection. Immunol. Rev. 2009, 227, 75-86.
27. Rusinova, I., Forster, S., Yu, S., Kannan, A. et al., Interferome v2.0: an updated database of annotated interferon-regulated genes. Nucleic Acids Res. 2013, 41, D1040-D1046.
28. Komarova, A. V., Combredet, C., Meyniel-Schicklin, L., Chapelle, M. et al., Proteomic analysis of virus-host interactions in an infectious context using recombinant viruses. Mol. Cell. Proteomics 2011, 10, M110 007443.
29. Hirsch, A. J., The use of RNAi-based screens to identify host proteins involved in viral replication. Future Microbiol. 2010, 5, 303-311.
30. Infante, R. E., Wang, M. L., Radhakrishnan, A., Kwon, H. J. et al., NPC2 facilitates bidirectional transfer of cholesterol between NPC1 and lipid bilayers, a step in cholesterol egress from lysosomes. Proc. Natl. Acad. Sci. U S A 2008, 105, 15287-15292.
31. Mueller, B., Klemm, E. J., Spooner, E., Claessen, J. H., Ploegh, H. L., SEL1L nucleates a protein complex required for dislocation of misfolded glycoproteins. Proc. Natl. Acad. Sci. U S A 2008, 105, 12325-12330.
32. Tortorella, D., Gewurz, B., Schust, D., Furman, M., Ploegh, H., Down-regulation of MHC class I antigen presentation by HCMV; lessons for tumor immunology. Immunol. Invest. 2000, 29, 97-100.
33. Ahn, K., Angulo, A., Ghazal, P., Peterson, P. A. et al., Human cytomegalovirus inhibits antigen presentation by a sequential multistep process. Proc. Natl. Acad. Sci. U S A 1996, 93, 10990-10995.
34. Bushman, F. D., Malani, N., Fernandes, J., D'Orso, I. et al., Host cell factors in HIV replication: meta-analysis of genome-wide studies. PLoS Pathog. 2009, 5, e1000437.
35. Ishigaki, Y., Li, X., Serin, G., Maquat, L. E., Evidence for a pioneer round of mRNA translation: mRNAs subject to nonsense-mediated decay in mammalian cells are bound by CBP80 and CBP20. Cell 2001, 106, 607-617.
36. Nojima, T., Hirose, T., Kimura, H., Hagiwara, M., The interaction between cap-binding complex and RNA export factor is required for intronless mRNA export. J. Biol. Chem. 2007, 282, 15645-15651.
37. Hadweh, P., Habelhah, H., Kieff, E., Mosialos, G., Hatzivassiliou, E., The PP4R1 subunit of protein phosphatase PP4 targets TRAF2 and TRAF6 to mediate inhibition of NF-kappaB activation. Cell. Signal. 2014, 26, 2730-2737.
38. Khan, K. A., Abbas, W., Varin, A., Kumar, A. et al., HIV-1 Nef interacts with HCV Core, recruits TRAF2, TRAF5 and TRAF6, and stimulates HIV-1 replication in macrophages. J. Innate Immun. 2013, 5, 639-656.
39. Deng, L., Wang, C., Spencer, E., Yang, L. et al., Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell 2000, 103, 351-361.
40. Alvarez, S. E., Harikumar, K. B., Hait, N. C., Allegood, J. et al., Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2. Nature 2010, 465, 1084-1088.
41. He, L., Grammer, A. C., Wu, X., Lipsky, P. E., TRAF3 forms heterotrimers with TRAF2 and modulates its ability to mediate NF-B activation. J. Biol. Chem. 2004, 279, 55855-55865.
42. Baud, V., Liu, Z. G., Bennett, B., Suzuki, N. et al., Signaling by proinflammatory cytokines: oligomerization of TRAF2 and TRAF6 is sufficient for JNK and IKK activation and target gene induction via an amino-terminal effector domain. Genes Dev. 1999, 13, 1297-1308.
43. Bagchi, P., Bhowmick, R., Nandi, S., Kant Nayak, M., Chawla-Sarkar, M., Rotavirus NSP1 inhibits interferon induced non-canonical NFkappaB activation by interacting with TNF receptor associated factor 2. Virology 2013, 444, 41-44.
44. Liu, S., Chen, J., Cai, X., Wu, J. et al., MAVS recruits multiple ubiquitin E3 ligases to activate antiviral signaling cascades. Elife 2013, 2, e00785.
45. Haga, I. R., Pechenick Jowers, T., Griffiths, S. J., Haas, J., Beard, P. M., TRAF2 facilitates vaccinia virus replication by promoting rapid virus entry. J. Virol. 2014, 88, 3664-3677.
46. Samuel, C. E., Antiviral actions of interferons. Clin. Microbiol. Rev. 2001, 14, 778-809, table of contents.
47. Lei, X., Liu, X., Ma, Y., Sun, Z. et al., The 3C protein of enterovirus 71 inhibits retinoid acid-inducible gene I-mediated interferon regulatory factor 3 activation and type I interferon responses. J. Virol. 2010, 84, 8051-8061.
48. Lei, X., Sun, Z., Liu, X., Jin, Q. et al., Cleavage of the adaptor protein TRIF by enterovirus 71 3C inhibits antiviral responses mediated by Toll-like receptor 3. J. Virol. 2011, 85, 8811-8818.
49. Akiyama, K., Kagawa, S., Tamura, T., Shimbara, N. et al., Replacement of proteasome subunits X and Y by LMP7 and LMP2 induced by interferon-gamma for acquirement of the functional diversity responsible for antigen processing. FEBS Lett. 1994, 343, 85-88.
50. Zhong, B., Yang, Y., Li, S., Wang, Y. Y. et al., The adaptor protein MITA links virus-sensing receptors to IRF3 transcription factor activation. Immunity 2008, 29, 538-550.
51. Anand, S. K., Tikoo, S. K., Viruses as modulators of mitochondrial functions. Adv. Virol. 2013, 2013, 738794.
52. Claus, C., Liebert, U. G., A renewed focus on the interplay between viruses and mitochondrial metabolism. Arch. Virol. 2013, 159, 1267-1277.
53. Shadel, G. S., Clayton, D. A., Mitochondrial DNA maintenance in vertebrates. Annu. Rev. Biochem. 1997, 66, 409-435.
54. Burger, G., Gray, M. W., Lang, B. F., Mitochondrial genomes: anything goes. Trends Genet. 2003, 19, 709-716.